News | October 28, 2021
Indian Pharma Market witnesses rise in volumes and prices in September.
Acute therapies continue to report strong growth compared to chronic ones.
Acute therapies continue to report strong growth compared to chronic ones.
Support from DFC will help produce one billion vaccine doses by the end of 2022
Aditya Puri former MD of HDFC bank joins Solara board as chairman
India business is growing as per projections; whereas US business will bounce back soon.
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
The U.S. Development Finance Corporation is funding a substantial expansion of manufacturing capability for BioE, the vaccine manufacturer in India
Strides Pharma Science Limited is pleased to announce that Aditya Puri joins the Strides Group as an Advisor and also will be a Director of its associate Company, Stelis Biopharma.
Subscribe To Our Newsletter & Stay Updated
